Healthmasters’ Magnesium Brain Food: Researchers in New Study Highlight Effects of Magnesium L-threonate on Cognitive Performance and Sleep

Magnesium is usually discussed as a muscle, relaxation, or general wellness mineral, but the newer research on magnesium L-threonate gives magnesium a much more specific brain-focused role. In a 2026 randomized, double-blind, placebo-controlled trial published in Frontiers in Nutrition, researchers tested whether Magnesium L-threonate could improve cognition, cognitive age, sleep quality, reaction time, and physiological markers of stress in healthy adults with self-reported dissatisfied sleep [1].

That study is directly relevant to Healthmasters’ Magnesium Brain Food because the product provides magnesium L-threonate, along with additional forms of magnesium, including di-magnesium malate and magnesium lysinate glycinate. The strongest clinical evidence reviewed here is specifically for magnesium L-threonate, so this article focuses primarily on that ingredient and what the 2026 trial actually found.

Why Magnesium L-Threonate Is Different

The researchers began with an important point: magnesium is required for more than 300 enzymatic reactions involved in energy generation, cardiovascular health, neuromuscular function, bone maintenance, cognition, and nervous system function. They also noted that roughly 50% of the U.S. population does not consume the recommended daily magnesium intake, while about 30% of the global population has inadequate magnesium intake.

But the study did not treat all magnesium forms as equal. The authors explained that many magnesium supplements may raise blood magnesium without meaningfully increasing magnesium levels in the brain because many forms have limited blood-brain permeability. That matters because a magnesium product intended for brain support should be judged not only by how much magnesium it contains, but by whether the form is designed to reach the nervous system.

Magnesium L-threonate was used in this study because preclinical research suggests magnesium L-threonate has greater brain bioavailability than other magnesium forms and can increase brain magnesium concentrations. The authors also noted that the L-threonate portion appears to help magnesium enter the brain through mechanisms involving glucose transporters, making the ingredient more brain-directed than ordinary magnesium salts.

The Study Design: A Real Clinical Test, Not Just Theory

The 2026 study was a 6-week, two-arm, parallel-group, randomized, double-blind, placebo-controlled trial. That design matters because participants were randomly assigned to magnesium L-threonate or placebo, both participants and researchers were blinded, and the placebo capsules were matched in appearance to the active capsules.

The trial included 100 healthy adults between 18 and 45 years old who reported dissatisfied sleep lasting longer than four weeks. The researchers selected people with sleep dissatisfaction because poor sleep is associated with worse cognitive performance, and the study was designed to avoid ceiling effects in otherwise healthy adults who might already perform well on cognitive tests.

Participants took 2 grams of magnesium L-threonate daily, split as one capsule in the morning and one capsule in the evening two hours before bedtime, for six weeks. Healthmasters’ Magnesium Brain Food contains 1 gram of magnesium L-threonate® magnesium L-threonate per scoop, meaning the trial dose corresponds to two 1-gram magnesium L-threonate servings per day.

Overall Cognition Improved More With Magnesium L-threonate

The study’s primary cognitive outcome was the NIH Toolbox Total Cognition Composite, which combines several measures of cognitive performance. After six weeks, the magnesium L-threonate group improved by an average of 8.40 points, while the placebo group improved by 5.60 points, and the difference between groups was statistically significant.

That means both groups improved, which is common in cognitive testing because people can perform better after becoming familiar with the tasks. The important point is that the magnesium L-threonate group improved more than the placebo group, suggesting that the change was not just practice effect.

In practical terms, the study suggests magnesium L-threonate helped support overall cognitive performance in adults who were healthy but experiencing dissatisfied sleep.

The “Cognitive Age” Finding: A 7.5-Year Difference

One of the most attention-grabbing findings was the study’s exploratory analysis of cognitive age. The researchers used NIH Toolbox age-related scoring to estimate how old a participant’s cognitive performance appeared relative to normative data.

At week six, the magnesium L-threonate group showed a difference equivalent to approximately 7.5 years of cognitive performance compared with placebo. The authors calculated this using the NIH Toolbox Total Cognition Composite Change Sensitive Score, based on the expected decline of about 0.3 points per year after age 20.

This does not mean magnesium L-threonate literally makes someone biologically 7.5 years younger. It means that, on this cognitive testing model, the improvement in the magnesium L-threonate group compared with placebo corresponded to a younger cognitive performance profile. That is still meaningful because it gives readers a concrete way to understand the cognitive change observed in the trial.

Working Memory: The Strongest Cognitive Signal

The study found a statistically significant improvement in the List Sorting Working Memory task for magnesium L-threonate compared with placebo. This task measures the ability to temporarily hold, organize, and reorder information, which is a core part of executive function.

This is the kind of memory people use when following multi-step instructions, keeping track of information during a conversation, mentally organizing tasks, or remembering what they were doing before being interrupted. The magnesium L-threonate group improved by 6.00 points on the List Sorting Working Memory task, while the placebo group improved by only 1.38 points, and the difference between groups was statistically significant.

The authors explained that working memory depends on prefrontal-parietal brain networks, which are involved in executive control and information management. They also suggested that magnesium L-threonate may have its strongest effects on cognitive domains related to synaptic plasticity and hippocampal function, including working memory and episodic memory.

Episodic Memory: A Strong Trend, But Not a Firm Finding

The study also found a strong trend toward improvement in the Picture Sequence Memory task, which measures episodic memory. Episodic memory is the ability to remember events, sequences, and experiences, and the authors noted that this kind of memory relies heavily on the hippocampus and medial temporal lobe networks.

The magnesium L-threonate group improved by 7.67 points on Picture Sequence Memory, while the placebo group improved by 4.68 points, but the between-group difference did not reach conventional statistical significance. The p-value was 0.092, which the authors described as a strong trend rather than a statistically significant result.

The study supports a stronger claim for working memory than for episodic memory, but the pattern still points in a favorable direction for magnesium L-threonate.

Reaction Time and Hand-Eye Coordination Improved

The study also included a digital reaction-time style test using a 3D Aim Trainer task. Participants were asked to shoot as many tiles as possible in 30 seconds, and the score reflected both speed and accuracy.

The magnesium L-threonate group improved by 3.59 points, which represented a 6.3% increase, while the placebo group did not significantly improve. The difference between groups was statistically significant.

The authors explained that hand-eye coordination reflects the brain’s ability to process visual information quickly and convert it into precise motor action. That makes the reaction-time finding useful because it shows the trial was not limited to abstract memory testing. It also measured a practical performance outcome involving visual processing, coordination, speed, and accuracy.

Sleep: Subjective Daytime Impairment Improved, Objective Sleep Did Not

The sleep findings were more mixed, and they need to be presented carefully. The study found that magnesium L-threonate produced a greater improvement in sleep-related impairment, which measures how sleep problems affect daytime functioning. The magnesium L-threonate group improved more than placebo on this measure, and the between-group difference was statistically significant.

However, magnesium L-threonate did not significantly outperform placebo on several other sleep outcomes, including overall sleep disturbance, restorative sleep, general wellbeing, or objective sleep measures from the Oura Ring. The researchers did find that among participants with more severe sleep disturbances at baseline, magnesium L-threonate improved sleep disturbance scores more than placebo.

This likely means that magnesium L-threonate improved sleep-related daytime impairment, and it may be more helpful for sleep disturbance in people with more severe baseline sleep problems. The objective sleep-tracker data did not show significant group differences in sleep outcomes, which keeps the sleep claim more modest.

Heart Rate and HRV: A Signal for Stress Balance

The Oura Ring data found no significant between-group differences in objective sleep outcomes, but it did show significant differences in physiological markers during sleep. The magnesium L-threonate group had a greater reduction in average sleeping heart rate compared with placebo.

The study also found a significant between-group difference in heart rate variability, measured by RMSSD. Heart rate variability is often used as a marker of autonomic balance, meaning the balance between the body’s stress-response system and recovery system.

The authors described the HRV finding as a physiological marker of stress reduction and improved autonomic balance. This does not necessarily prove that magnesium L-threonate treats stress disorders, but it suggests that agnesium L-threonate may support a calmer physiological state during sleep.

This fits the real-world experience many people are looking for from magnesium: not sedation, but better nervous system regulation.

Safety and Tolerability

Magnesium L-threonate was well tolerated in the six-week trial. The study reported no significant adverse reactions.

Conclusion

Most magnesium products are designed around general relaxation, muscle comfort, or basic mineral replacement. Healthmasters’ Magnesium Brain Food is different because it includes magnesium L-threonate, a magnesium form studied for cognitive performance, working memory, cognitive age, and nervous system balance and the same branded ingredient tested in the 2026 randomized, double-blind, placebo-controlled trial.

The reviewed study used 2 grams of magnesium L-threonate daily for six weeks, whereas Healthmasters’ Magnesium Brain Food contains 1 gram of magnesium L-threonate per scoop, making the study dose highly uniquely relevant.

The 2026 clinical trial does not prove that magnesium L-threonate cures cognitive decline, sleep disorders, or neurological disease. However, in it, researchers did explain how it tended to show that six weeks of magnesium L-threonate supplementation improved overall cognition, working memory, reaction-time performance, estimated cognitive age, sleep-related impairment, sleeping heart rate, and HRV in healthy adults with dissatisfied sleep.

Reference

[1] Lopresti, A. L., & Smith, S. J. (2026). The effects of magnesium L-threonate (Magnesium L-threonate®) on cognitive performance and sleep quality in adults: A randomised, double-blind, placebo-controlled trial. Frontiers in Nutrition, 12, 1729164. https://doi.org/10.3389/fnut.2025.1729164

*The matters discussed in this article are for informational purposes only and not medical advice. Please consult your healthcare practitioner on the matters discussed herein.

*These statements have not been evaluated by the Food and Drug Administration. Healthmasters' products are not intended to diagnose, treat, cure, or prevent any disease.